These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19217217)

  • 1. Dysadherin expression in gastrointestinal stromal tumors (GISTs).
    Liang JF; Zheng HX; Xiao H; Li N; Cheng CX; Wang HK
    Pathol Res Pract; 2009; 205(7):445-50. PubMed ID: 19217217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.
    Tamura M; Ohta Y; Tsunezuka Y; Matsumoto I; Kawakami K; Oda M; Watanabe G
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):740-5. PubMed ID: 16153922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy.
    Muramatsu H; Akimoto T; Maebayashi K; Kita M; Mitsuhashi N
    Anticancer Res; 2008; 28(6B):3859-64. PubMed ID: 19192641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
    Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
    Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma.
    Shimada Y; Hashimoto Y; Kan T; Kawamura J; Okumura T; Soma T; Kondo K; Teratani N; Watanabe G; Ino Y; Sakamoto M; Hirohashi S; Imamura M
    Oncology; 2004; 67(1):73-80. PubMed ID: 15459499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
    Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
    Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin L is highly expressed in gastrointestinal stromal tumors.
    Miyamoto K; Iwadate M; Yanagisawa Y; Ito E; Imai J; Yamamoto M; Sawada N; Saito M; Suzuki S; Nakamura I; Ohki S; Saze Z; Kogure M; Gotoh M; Omicronbara K; Ohira H; Tasaki K; Abe M; Goshima N; Watanabe S; Waguri S; Takenoshita S
    Int J Oncol; 2011 Nov; 39(5):1109-15. PubMed ID: 21769426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
    Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
    Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.
    Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K
    Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions.
    Haller F; Löbke C; Ruschhaupt M; Schulten HJ; Schwager S; Gunawan B; Armbrust T; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Oct; 216(2):225-35. PubMed ID: 18729075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct gene expression-defined classes of gastrointestinal stromal tumor.
    Yamaguchi U; Nakayama R; Honda K; Ichikawa H; Hasegawa T; Shitashige M; Ono M; Shoji A; Sakuma T; Kuwabara H; Shimada Y; Sasako M; Shimoda T; Kawai A; Hirohashi S; Yamada T
    J Clin Oncol; 2008 Sep; 26(25):4100-8. PubMed ID: 18757323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated expression of Snail and E-cadherin correlates with gastrointestinal stromal tumor metastasis.
    Liu S; Liao G; Ding J; Ye K; Zhang Y; Zeng L; Chen S
    Eur J Cancer Prev; 2014 Sep; 23(5):329-35. PubMed ID: 24999604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
    Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L
    Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors.
    Li CF; Huang WW; Wu JM; Yu SC; Hu TH; Uen YH; Tian YF; Lin CN; Lu D; Fang FM; Huang HY
    Clin Cancer Res; 2008 Dec; 14(23):7822-31. PubMed ID: 19047110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
    Liang YM; Li XH; Chen W
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal stromal tumors regularly express synaptic vesicle proteins: evidence of a neuroendocrine phenotype.
    Bümming P; Nilsson O; Ahlman H; Welbencer A; Andersson MK; Sjölund K; Nilsson B
    Endocr Relat Cancer; 2007 Sep; 14(3):853-63. PubMed ID: 17914114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.
    Suehara Y; Kondo T; Seki K; Shibata T; Fujii K; Gotoh M; Hasegawa T; Shimada Y; Sasako M; Shimoda T; Kurosawa H; Beppu Y; Kawai A; Hirohashi S
    Clin Cancer Res; 2008 Mar; 14(6):1707-17. PubMed ID: 18347171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revision of gastrointestinal mesenchymal tumors.
    Sornmayura P; Howannapakorn J; Karnsombut P
    J Med Assoc Thai; 2009 Jan; 92(1):87-95. PubMed ID: 19260248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.